Dudediligence.

Creative Medical Technology Holdings, Inc

CELZNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$0.00Sep ’24$3,000Dec ’24$3,000Mar ’25$0.00Jun ’25$0.00Sep ’25$3,000Dec ’25$0.00Mar ’26$0.00Jun ’26
Net income, by quarter
−$1.0MSep ’24−$1.9MDec ’24−$1.6MMar ’25−$1.2MJun ’25−$1.2MSep ’25−$1.9MDec ’25−$1.4MMar ’26−$1.5MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$87,754$88,600$9,000$11,000$6,000
Gross profit$39,805$60,109$5,400$6,600$3,806
Operating income−$3.1M−$10.2M−$5.6M−$5.7M−$6.1M
Net income$19.2M−$10.1M−$5.3M−$5.5M−$6.0M
Operating cash flow−$2.2M−$7.8M−$8.0M−$5.3M−$5.9M
Cash$10.7M$8.3M$3.5M$5.9M$7.2M
Shares outstanding6.3M1.4M1.4M1.7M3.7M